Verastem Inc (VSTM):企業の財務・戦略的SWOT分析

◆英語タイトル:Verastem Inc (VSTM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH289833FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verastem Inc (Verastem) is a biopharmaceutical company which focus on the discovery, development and commercialization of novel small molecule drugs to treat cancer. The company’s marketed product COPIKTRA, an oral inhibitor of phosphoinositide 3-kinase (PI3K) is used to hematologic malignancies. Its pipeline products include VS-6766 a unique inhibitor of the RAF/MEK signaling pathway is used for the treatment of certain types of hematologic and solid cancers, T-cell lymphoma, lung cancer, neck cancer, mesothelioma, ovarian cancer and other advanced cancers. The company operates laboratory in Needham, Massachusetts, the US and has operational presence in Germany. Verastem is headquartered in Needham, Massachusetts, the US.

Verastem Inc Key Recent Developments

Mar 18,2021: Verastem Oncology Reports Fourth Quarter and Full Year 2020 Financial Results, Clinical Updates and Guidance for Key Milestones in 2021 and 1H 2022
Mar 02,2021: Verastem Oncology to Participate in the H.C. Wainwright Global Life Sciences Conference
Jan 20,2021: Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology
Jan 06,2021: Verastem Oncology Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer

This comprehensive SWOT profile of Verastem Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Verastem Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Verastem Inc – Key Information
Verastem Inc – Overview
Verastem Inc – Key Employees
Verastem Inc – Key Employee Biographies
Verastem Inc – Key Operational Heads
Verastem Inc – Major Products and Services
Verastem Inc – History
Verastem Inc – Company Statement
Verastem Inc – Locations And Subsidiaries
Verastem Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Verastem Inc – Business Description
Verastem Inc – Corporate Strategy
Verastem Inc – SWOT Analysis
SWOT Analysis – Overview
Verastem Inc – Strengths
Verastem Inc – Weaknesses
Verastem Inc – Opportunities
Verastem Inc – Threats
Verastem Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Verastem Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Verastem Inc, Key Information
Verastem Inc, Key Ratios
Verastem Inc, Share Data
Verastem Inc, Major Products and Services
Verastem Inc, History
Verastem Inc, Key Employees
Verastem Inc, Key Employee Biographies
Verastem Inc, Key Operational Heads
Verastem Inc, Other Locations
Verastem Inc, Subsidiaries
Verastem Inc, Key Competitors
Verastem Inc, SWOT Analysis
Verastem Inc, Ratios based on current share price
Verastem Inc, Annual Ratios
Verastem Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Verastem Inc (VSTM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Provectus Biopharmaceuticals Inc (PVCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Apetit Oyj:企業の戦略・SWOT・財務情報
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • GWA Group Ltd (GWA):企業の財務・戦略的SWOT分析
    GWA Group Ltd (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Seacor Holdings Inc (CKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Seacor Holdings Inc (Seacor) is a diversified holding company that offers domestic and international transportation and logistics and risk management consultancy services. The company operates through business segments such as ocean transportation and logistics services, inland transportatio …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …
  • Trinity Biotech Plc (TRIB):医療機器:M&Aディール及び事業提携情報
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology engaged in the development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products which include MGN1601, and others. It also engaged in developing EnanDIM product to treat antitumor efficacy by stimulatin …
  • Par Pacific Holdings, Inc. (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings, Inc. (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Zargon Oil & Gas Ltd (ZAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Zargon Oil & Gas Ltd (Zargon) is an upstream energy company. It carries out the exploration, development and production of oil and natural gas. The company’s core business is oil exploitation in the Western Canadian and Williston sedimentary basins. The company also specializes in all three …
  • Aevis Victoria SA (AEVS):企業の財務・戦略的SWOT分析
    Aevis Victoria SA (AEVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Industrial Alliance Insurance and Financial Services Inc.:企業の戦略・SWOT・財務情報
    Industrial Alliance Insurance and Financial Services Inc. - Strategy, SWOT and Corporate Finance Report Summary Industrial Alliance Insurance and Financial Services Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the co …
  • Indianapolis Power & Light Co-エネルギー分野:企業M&A・提携分析
    Summary Indianapolis Power & Light Co (IPL), a subsidiary of IPALCO Enterprises Inc, is an integrated electric utility. The company generates, transmits, distributes, and sells electric energy. It produces electricity from coal, oil, and natural gas sources. IPL owns and operates power plants in Ind …
  • InnoPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary InnoPharma Inc (InnoPharma), a subsidiary of Pfizer Inc is a healthcare products provider that develops generic and pharmaceutical products. The company develops formulations, which include solutions, suspensions, lyophilized, emulsions, liposomes, lipid complexes, polypeptides and carbohydr …
  • ESSA Pharma Inc (EPI):企業の財務・戦略的SWOT分析
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • CEPS A.S.:発電所・企業SWOT分析
    CEPS A.S. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Silgan Holdings Inc.:企業の戦略・SWOT・財務情報
    Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hagoromo Foods Corporation:企業の戦略・SWOT・財務情報
    Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PTC Therapeutics Inc (PTCT)-製薬・医療分野:企業M&A・提携分析
    Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mu …
  • IDT Corp (IDT):企業の財務・戦略的SWOT分析
    Summary IDT Corp (IDT) is a telecommunication service provider that offers mobile application development and telecommunication services. The company provides prepaid communication and payment services and international voice termination through its retail and wholesale division. It offers services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆